First drug to delay onset of type 1 diabetes made available on NHS

The immunotherpay can give children and adults three extra years before they need to use insulin.

Drug that delays onset of type 1 diabetes approved in England and Wales

Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’ The world’s first drug to delay the onset of type 1 diabetes is to be made available on the NHS in England and Wales, in the biggest breakthrough in tackling the disease for more than a century. Millions of people have type 1 diabetes worldwide, which typically emerges during childhood or adolescence, and occurs when the pancreas makes little or no insuli...

By Andrew Gregory Health editor

Diabetes cure finally found? First drug treating type 1 diabetes made available

In a landmark announcement, the NHS has introduced a beacon of hope for individuals susceptible to type 1 diabetes. Teplizumab, an innovative medication, is now able to delay the disease's onset for an average of three years, focusing on the autoimmune process impacting the pancreas. This breakthrough provides vital time for young patients, allowing them to manage their health more effectively before the disease fully manifests.

By TOI LIFESTYLE DESK